Last updated: April 24, 2026

Application No. 19/389,403

Untitled Application

Unknown

Filed

1600

Examiner

CARTER, SANDRA DILLAHUNT

Art Unit

1674

Tech Center

NOVARTIS AG

Assignee

Novartis AG

OA Round

1 (Non-Final)

This examiner grants 55% of cases after interview

— +29.6% interview lift. A telephonic interview to clarify the technical implementation could significantly improve the outcome.

Based on 504 resolved cases, 2023–2026

Examiner Intelligence

CARTER, SANDRA DILLAHUNT View full profile →

Grants 55% of resolved cases

Career Allow Rate

279 granted / 504 resolved

-4.6% vs TC avg

Strong +30% interview lift

Without

With

+29.6%

Interview Lift

resolved cases with interview

Typical timeline

3y 10m

Avg Prosecution

43 currently pending

Career history

547

Total Applications

across all art units

Statute-Specific Performance

§101

7.4%

-32.6% vs TC avg

§103

21.0%

-19.0% vs TC avg

§102

15.5%

-24.5% vs TC avg

§112

36.3%

-3.7% vs TC avg

Black line = Tech Center average estimate • Based on career data from 504 resolved cases

Prosecution Timeline

1600

Application Filed

Mar 07, 2026

Non-Final Rejection (current)

Precedent Cases

Applications granted by this same examiner with similar technology

18/321,405

Patent 12601746

BIOMARKERS OF RENAL INJURY

2y 5m to grant Granted Apr 14, 2026

18/481,213

Patent 12599664

PHARMACEUTICAL PRODUCTS AND STABLE LIQUID COMPOSITIONS OF IL-17 ANTIBODIES

2y 5m to grant Granted Apr 14, 2026

15/073,021

Patent 12595297

METHODS AND COMPOSITIONS FOR INHIBITION OF EGF/EGFR PATHWAY IN COMBINATION WITH TYROSINE KINASE INHIBITORS

2y 5m to grant Granted Apr 07, 2026

18/464,421

Patent 12569565

COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS

2y 5m to grant Granted Mar 10, 2026

18/224,384

Patent 12558369

COMPOSITIONS AND METHODS OF TREATING FANCONI ANEMIA

2y 5m to grant Granted Feb 24, 2026

Study what changed to get past this examiner. Based on 5 most recent grants.

AI Strategy Recommendation

Get an AI-powered prosecution strategy using examiner precedents, rejection analysis, and claim mapping.

Prosecution Projections

1-2

Expected OA Rounds

55%

Grant Probability

85%

With Interview (+29.6%)

3y 10m

Median Time to Grant

Low

PTA Risk

Based on 504 resolved cases by this examiner. Grant probability derived from career allow rate.